GRFS

Grifols S A

• Seeking Alpha·07/03 14:49

  Grifols: Operational Recovery And Balance Sheet Improvement Support A Return To Buy (Rating Upgrade)

• PUBT·07/03 13:23

  Grifols’ Albert Grifols receives EUR 2.89 million in shares via family wealth restructuring

• Reuters·07/01 05:23

  BRIEF-Grifols Reorganizes Operating Model, Creates Separate U.S. And Rest-Of-World Biopharma Units

• PUBT·07/01 05:01

  Grifols shifts to two-system plasma model to boost regional self-sufficiency

• PUBT·07/01 05:00

  Idorsia names Roland Wandeler CEO effective Oct. 1, 2026

• TipRanks·06/22 18:47

  Grifols Reshapes Board and ESG Committee Following Director Resignation

• PUBT·06/22 18:19

  Grifols names Ester Masllorens Llinàs to board as independent director after Felip Font resignation

• TipRanks·06/18 20:31

  Grifols Shareholders Approve 2025 Accounts and July Dividend, Renew Deloitte Mandate

• PUBT·06/18 15:06

  Grifols shareholders approve up to 10% share capital cut via treasury share cancellations

• PUBT·06/16 20:25

  Rigel Pharmaceuticals publishes corporate presentation outlining commercial growth strategy and pipeline priorities

• TipRanks·06/15 12:50

  Grifols announces U.S. launch of new fibrinogen concentrate

• Reuters·06/15 12:05

  GRIFOLS - ANNOUNCES U.S. LAUNCH OF NEW FIBRINOGEN CONCENTRATE

• Reuters·06/15 12:01

  GRIFOLS - LAUNCHES NEW FIBRINOGEN CONCENTRATE FESILTY (FIBRINOGEN, HUMAN-CHMT) IN THE U.S.

• Reuters·06/15 12:01

  GRIFOLS - FESILTY TO BE USED FOR ACUTE BLEEDING EPISODES IN PEDIATRIC AND ADULT PATIENTS WITH CONGENITAL FIBRINOGEN DEFICIENCY

• PUBT·06/12 09:24

  Grifols to invest EUR 180 million in Egypt plasma-derivatives expansion through 2029